Besthof Robert's Form 4 filing
NRX Pharmaceuticals, Inc. (NRXP) · filed Nov 2, 2021
- Accession no.
- 0000950142-21-003503
- Filed
- Nov 2, 2021, 4:04 PM ET
- Trade date
- Aug 16-Sep 15, 2021
- Filing delay
- 78 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $470.4K. It was filed 78 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Besthof RobertCIK 0001864650 | Officer (Chief Comm. & Patient Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | MOption exerciseAcquired | +63,710 | $0.20 | +$12,742 | 63,710 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −40,000 | $11.76 | −$470,400 | 23,710 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | CConversionDisposed | −100,000 | $0.20 | −$20,000 | 247,200 | Direct | |
| Aug 16, 2021 | Common Stock | AGrant or awardAcquired | +36,290 | $0.00 | $0 | 36,290 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.